June 2024 Publications
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. Dos Santos PCP, Messina NL, de Oliveira RD, da Silva PV, Puga MAM, Dalcolmo M, Dos Santos G, de Lacerda MVG, Jardim BA, de Almeida E Val FF, Curtis N, Andrews JR, Croda J. Lancet Infect Dis. 2024 Jun. doi: 10.1016/S1473-3099(23)00818-6. Epub 2024 Feb 26.
- Inhaled aerosol viral-vectored vaccines against tuberculosis. Stylianou E, Satti I. Curr Opin Virol. 2024 Jun. doi: 10.1016/j.coviro.2024.101408. Epub 2024 Apr 3.
- Cell-Mediated Immune Response Against Mycobacterium tuberculosisand its Potential Therapeutic Impact. Khanna H, Gupta S, Sheikh Y. J Interferon Cytokine Res. 2024 Jun. doi: 10.1089/jir.2024.0030. Epub 2024 Apr 12.
- Revaccination with BCG: does it work? McShane H. Lancet Infect Dis. 2024 Jun. doi: 10.1016/S1473-3099(24)00006-9. Epub 2024 Feb 26.
- Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. Weng S, Li Q, Zhang T, Lin T, He Y, Yang G, Wang H, Xu Y. Vaccines (Basel). 2024 Jun 4. doi: 10.3390/vaccines12060622.
- TB and HIV induced immunosenescence: where do vaccines play a role? Singh M, Patel B, Seo M, Ahn P, Wais N, Shen H, Nakka S, Kishore P, Venketaraman V. Front Aging. 2024 Jun 5. doi: 10.3389/fragi.2024.1385963.
- Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. Rungelrath V, Ahmed M, Hicks L, Miller SM, Ryter KT, Montgomery K, Ettenger G, Riffey A, Abdelwahab WM, Khader SA, Evans JT. NPJ Vaccines. 2024 Jun 6. doi: 10.1038/s41541-024-00897-x.
- Novel Targets for the Development of Tuberculosis Vaccine. Joshi R, Sheth D, Beladiya J, Patel C, Solanki N, Dalal M, Kyada A, Patel SB. Curr Drug Discov Technol. 2024 Jun 7. doi: 10.2174/0115701638285518240601075811. Epub ahead of print.
- Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route. Audran R, Karoui O, Donnet L, Soumas V, Fares F, Lovis A, Noirez L, Cavassini M, Fayet-Mello A, Satti I, McShane H, Spertini F. J Infect. 2024 Jun 17. doi: 10.1016/j.jinf.2024.106205. Epub ahead of print.
- Promotion of Th17 Polarized Immunity via Co-Delivery of Mincle Agonist and Tuberculosis Antigen Using Silica Nanoparticles. Abdelwahab WM, Le-Vinh B, Riffey A, Hicks L, Buhl C, Ettenger G, Jackson KJ, Weiss AM, Miller S, Ryter K, Evans JT, Burkhart DJ. ACS Appl Bio Mater. 2024 Jun 17. doi: 10.1021/acsabm.4c00245. Epub 2024 Jun 4.
- Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis. Dintwe OB, Ballweber Fleming L, Voillet V, McNevin J, Seese A, Naidoo A, Omarjee S, Bekker LG, Kublin JG, De Rosa SC, Newell EW, Fiore-Gartland A, Andersen-Nissen E, McElrath MJ. Nat Commun. 2024 Jun 18. doi: 10.1038/s41467-024-49050-1.
- Macrophages exploit the mannose receptor and JAK-STAT1-MHC-II pathway to drive antigen presentation and the antimycobacterial immune response after BCG vaccination. Zhang Y, Xu D, Nie Q, Wang J, Fang D, Xie Y, Xiong H, Pan Q, Zhang XL. Acta Biochim Biophys Sin (Shanghai). 2024 Jun 19. doi: 10.3724/abbs.2024100. Epub ahead of print.
- Mycobacterium tuberculosis strain with deletions in menT3 and menT4 is attenuated and confers protection in mice and guinea pigs. Gosain TP, Chugh S, Rizvi ZA, Chauhan NK, Kidwai S, Thakur KG, Awasthi A, Singh R. Nat Commun. 2024 Jun 27. doi: 10.1038/s41467-024-49246-5.